Why CorVel’s AI rollout matters for stock watchers

CorVel (CRVL) has launched CorVel Connected, a suite of artificial intelligence tools inside its CareMC claims platform, designed to organize complex claim data, support faster decisions, and reduce manual workload for claims professionals.

CorVel’s 19.3% 3 month share price return and 5.6% 1 month share price return suggest some near term momentum, although the 1 year total shareholder return of 48.3% decline points to a tougher longer term picture.

If CorVel’s push into AI powered claims tools has your attention, this can be a useful moment to size up other AI focused opportunities using our 62 profitable AI stocks that aren't just burning cash

With CorVel trading at US$58.06 and an estimated intrinsic value gap of about 39%, recent share price weakness and the new AI rollout raise a key question for you: is this a genuine mispricing, or is the market already looking ahead?

Price to earnings of 28.1x: Is it justified?

On a P/E of 28.1x, CorVel looks cheaper than its direct peers but more expensive than the broader US Healthcare sector. This sends a mixed valuation signal at the current $58.06 share price.

The P/E ratio compares the current share price to earnings per share and is often used to see how much investors are paying for each dollar of profit. For CorVel, this sits alongside several earnings quality markers, including 19.9% earnings growth over the past year, a 14.9% per year earnings growth figure over the past 5 years, and a high 28.1% return on equity.

This combination suggests the market is paying up for a business with a solid profitability profile, but not as much as for peers on an average P/E of 53.8x. Against that, the stock trades on a richer multiple than the US Healthcare industry average of 22.4x. As a result, the valuation sits between sector and peer benchmarks rather than clearly cheap or clearly expensive.

Compared with peers, CorVel screens as good value on its 28.1x P/E versus the 53.8x peer average. Yet within the wider industry it looks expensive against the 22.4x P/E benchmark. That split view means the justification for today’s multiple largely rests on how investors weigh its earnings quality and recent growth against its weaker 1 year share price return.

Result: Price to earnings of 28.1x (ABOUT RIGHT)

However, recent 1 year and 3 year total returns in decline, alongside year to date weakness, suggest that sentiment can stay fragile if AI execution disappoints.

Another view on CorVel’s value

The P/E discussion paints CorVel as somewhere between cheap and expensive, but the SWS DCF model is more decisive. With an estimated future cash flow value of $95.59 versus a $58.06 share price, the model points to CorVel trading at a 39.3% discount. This raises a different question: is the market too pessimistic on the stock, or is the model assuming more than you are comfortable with?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CorVel for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals here leave you undecided, now is a good time to look through the numbers yourself and weigh both the concerns and the upside. To see how the balance of potential risks and rewards compares in one place, start with the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If CorVel has piqued your interest, do not stop there. Broaden your watchlist now and give yourself more options before the next move in markets.

• Grow your pool of potential bargains by scanning 51 high quality undervalued stocks that combine robust fundamentals with attractive pricing signals.
• Strengthen your focus on resilience by reviewing 72 resilient stocks with low risk scores that score well on stability and downside protection.
• Spot underfollowed opportunities early by checking the screener containing 23 high quality undiscovered gems before they appear on everyone else's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.